In vitro effects of voxelotor on red blood cell senescence and rheological behavior in sickle cell anemia
Authors:
- 30 April 2026
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 119, 103007
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 30 references indexed in Scilit:
- PRELIMINARY RESULTS FROM A MULTICENTER PHASE 2/3 STUDY OF NEXT-GENERATION SICKLE HEMOGLOBIN POLYMERIZATION INHIBITOR OSIVELOTOR (GBT021601) FOR THE TREATMENT OF PATIENTS WITH SICKLE CELL DISEASEHematology, Transfusion and Cell Therapy, 2024
- Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE‐KIDS 1 trialeJHaem, 2024
- 5-Hydroxymethylfurfural Exerts Negative Effects on Gastric Mucosal Epithelial Cells by Inducing Oxidative Stress, Apoptosis, and Tight Junction DisruptionJournal of Agricultural and Food Chemistry, 2022
- A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseNew England Journal of Medicine, 2019
- Impact of surface-area-to-volume ratio, internal viscosity and membrane viscoelasticity on red blood cell deformability measured in isotonic conditionScientific Reports, 2019
- Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patientsAmerican Journal of Hematology, 2019
- Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell diseaseBritish Journal of Clinical Pharmacology, 2019
- The role of blood rheology in sickle cell diseaseBlood Reviews, 2016
- Effects of oxidative stress on red blood cell rheology in sickle cell patientsBritish Journal of Haematology, 2014
- Haemolysis and abnormal haemorheology in sickle cell anaemiaBritish Journal of Haematology, 2014